Immunovia AB设定演习价格,为美国试验发射和研究获得资金。 Immunovia AB sets warrant exercise price, secures funds for US test launch and studies.

Immunovia AB规定,从2025年1月2日到1月16日,Immunovia AB为第2号授权令系列设定0.46瑞典克朗的实算价。 Immunovia AB has set an exercise price of SEK 0.46 for its warrants series TO 2, with the exercise period from January 2 to January 16, 2025. 该公司通过认购和担保获得了约 65% 的认股权证计划，金额为 3720 万瑞典克朗。 The company has secured around 65% of the warrant program, amounting to SEK 37.2 million, through subscriptions and guarantees. 这些资金将用于今年晚些时候在美国市场启动下一代测试,并支持临床研究,以便偿还费用。 These funds will be used to launch a next-generation test in the US market later this year and to support clinical studies for reimbursement.